Healthcare and life sciences combine repetitive information work with strict limits on disclosure and error. Qua would keep approved answers and enterprise retrieval inside the perimeter, escalating only authorised tasks that need additional reasoning.
Industry thesis — modelled, not deployed. Figures are potential savings.
$5.3tnUS health expenditure, 2024Centers for Medicare & Medicaid Services, 2025
18.0%US GDP share spent on health, 2024Centers for Medicare & Medicaid Services, 2025
46CDER novel drug approvals, 2025US Food and Drug Administration, January 2026
Healthcare & life sciences — the cheapest trustworthy source answers first; frontier reasoning is paid for only when it earns its price.
Where the money goes today
Healthcare & life sciences: the cost of asking
CMS reported in 2024 that US national health expenditure reached $5.3 trillion in 2023, representing 18.0% of GDP. Those figures describe the healthcare economy, not an addressable AI budget or a forecast of savings.
The FDA's 2024 novel drug approvals record lists 50 approvals by its Center for Drug Evaluation and Research. Development and post-approval work involve controlled evidence, protocols and review processes where retrieval and generation serve different purposes.
IBM's 2024 Cost of a Data Breach Report put the average healthcare breach cost at $7.42 million. That industry benchmark supports a privacy-first design thesis, but it does not quantify the risk reduction Qua would deliver.
Three pressures
What makes this industry different
Sensitive Data Before Routing
Patient and participant information cannot be treated as ordinary prompt content. Permissions, masking and deployment boundaries would need to be established before a model is considered.
Current Evidence Over Fluency
A fluent answer can still cite a superseded protocol. Responses would need source versions, effective dates and explicit handling of missing evidence.
Human Accountability Remains Essential
Clinical, safety and regulatory decisions carry responsibilities that routing cannot remove. Any pilot would separate administrative assistance from decisions requiring qualified review.
Five applications
How Qua would run inside healthcare & life sciences
Each application is a real workflow, mapped to the tier that could answer it. The waterfall tries the cheapest trustworthy source first and only pays a frontier model when the expected value clears the gate.
Approved trial-site FAQ lookup
Resolves at Personal Knowledge~20,000 questions/month
Site teams would reuse approved administrative answers with visible version information. Participant-specific eligibility and treatment questions would remain outside this workflow.
Potential saving — 90-100% of query spend.
Apply study-role permissions, identifier masking and an Enterprise Search maximum-tier clamp.
Check verified Personal Knowledge answers against the current protocol version.
On a miss, search approved site guidance inside the perimeter or return unresolved.
Protocol and SOP evidence retrieval
Resolves at Enterprise Search~40,000 questions/month
Research staff would locate governing instructions without sending documents to an external model. Each receipt would state exact query cost, the premium baseline cost, savings and what stayed private.
Potential saving — 85-100% of query spend.
Enforce study access, effective-document filters and external-provider blocks.
Check verified answers, then search authorised protocols and SOPs inside the perimeter.
Return grounded passages with document versions or abstain when evidence is absent.
Pharmacovigilance intake normalisation
Resolves at Fast Models~30,000 questions/month
Safety teams would receive draft extraction with source passages and missing fields marked. Qualified reviewers would retain responsibility for case validity, causality, reportability and submission deadlines.
Potential saving — 70-90% of query spend.
Minimise identifiers and restrict processing to an authorised deployment and provider.
Check approved mappings, then retrieve the controlled intake schema.
Use Fast Models to draft structured fields only when cheaper tiers cannot complete them.
Referral letter drafting
Resolves at Fast Models~5,000 questions/month
Clinicians would review a sourced draft rather than start from a blank document. The workflow would neither infer diagnoses nor send a referral without human approval.
Potential saving — 70-90% of query spend.
Apply patient-record permissions, minimum-necessary filters and a Fast Models tier clamp.
Check approved templates, then retrieve only authorised referral facts.
Use an authorised Fast Model for drafting or stop if no permitted route exists.
Protocol deviation evidence comparison
Resolves at Pro Models~5,000 questions/month
Reviewers would receive a structured comparison of events, protocol requirements and unresolved evidence. Premium reasoning would support expert assessment, not determine participant care or final deviation classification.
Potential saving — 0-25% of query spend.
Apply study permissions, pseudonymisation and permitted-provider restrictions.
Check prior approved assessments, retrieve current evidence and assess Fast Models capability.
Escalate only when the expected-value gate clears and the permitted route meets review requirements.
The modelled ledger
What the same year of questions could cost
A thesis, not a case history. The assumptions are stated so you can replace them with your own numbers — which is exactly what a pilot does in week one.
Ledger rates are the vendors’ own published list prices: $0.0150 per premium question and $0.00065 per fast question at 1,500 input / 700 output tokens.
Modelled annual comparison
Workload: 100,000 questions/month for 12 months, at 1,500 input and 700 output tokens per question.
Published list prices, not estimates — premium baseline xAI Grok 4 at $3.00/$15.00 per 1M tokens = $0.0150/question.
Cheap metered tier xAI Grok 4 Fast at $0.20/$0.50 per 1M tokens = $0.00065/question.
Terminal-tier mix: 60% verified or in-perimeter, 35% Fast Models, 5% Pro Models. Rows exclude Qua fees, retrieval infrastructure, integration and human review.
WorkloadFrontier-onlyWith Qua
Verified answers and in-perimeter search720,000 annual questions resolved with no external model call.$10,800$0
Fast Models (Grok 4 Fast)420,000 annual questions at xAI's published Grok 4 Fast rate ($0.00065/question).$6,300$273
EV-gated Pro Models (Grok 4)60,000 annual questions keep frontier reasoning at the published Grok 4 rate.$900$900
At published vendor prices this thesis models $16,827 of avoided annual inference spend — $18,000 down to $1,173, a 93.5% reduction — before the excluded costs above.
Controls that matter here
Policy runs before routing, not after
Minimum Necessary Health Access
For HIPAA's minimum-necessary requirements where applicable, Qua would enforce role access, masking and provider blocks before routing. A VPC or air-gapped deployment could support boundary requirements, but HIPAA obligations and any required business associate agreements would still need assessment.
Special Category Data Boundaries
For GDPR Article 9, the organisation would need an applicable processing condition alongside its Article 6 lawful basis. Qua's policy engine would constrain permitted processing routes, while international transfers would require a separate Chapter V assessment.
Validated Research Audit Trails
Where FDA 21 CFR Part 11 applies, a pilot would assess validation, access controls, audit trails, retention and electronic-signature requirements. Answer receipts would support traceability but would not alone establish Part 11 compliance.
In week one, measure answer correctness, citation version accuracy and abstention on a de-identified, expert-reviewed test set.
In week one, test seeded patient-identifier leakage and verify that blocked providers receive no requests.
In week one, compare provider spend, escalation rates and reviewer correction time with an authorised premium-only baseline.
Sources
Every figure on this page, traceable
Market figures come from the publishers below. Qua savings are modelled from the vendors’ published list prices — they are not customer results.
[1]Centers for Medicare & Medicaid Services, National Health Expenditure Accounts — 2023 expenditure data released in 2024 (2024). Source CMS's 2024 release reported US national health expenditure of $5.3 trillion in 2023, representing 18.0% of GDP; these are healthcare-economy measures, not an AI budget.
[2]US Food and Drug Administration, New Drug Therapy Approvals 2025 (2026). Source FDA's Center for Drug Evaluation and Research approved 46 novel drugs in 2025; this count does not cover every FDA approval category.
[3]IBM, Cost of a Data Breach Report 2024 (2024). Source IBM's 2024 study reported an average healthcare breach cost of $7.42 million; this does not establish the risk reduction achievable by a particular product.
[4]US Department of Health and Human Services, Minimum Necessary Requirement (n.d.). Source HIPAA generally requires reasonable efforts to limit protected-health-information use, disclosure and requests to the minimum necessary, with specified exceptions including treatment disclosures.
[5]European Union, Regulation (EU) 2016/679 — General Data Protection Regulation, Articles 5, 6, 9 and 32 (2016). Source GDPR treats health data as special-category personal data; covered processing needs an applicable Article 9 condition alongside a lawful basis and appropriate safeguards.
[6]US Food and Drug Administration / Electronic Code of Federal Regulations, 21 CFR Part 11 — Electronic Records; Electronic Signatures (n.d.). Source Where FDA Part 11 applies, closed electronic-record systems require validation, access controls and secure time-stamped audit trails; this is not a blanket requirement for all research AI.
